Efficacy of subsequent cytotoxic chemotherapy after nivolumab for patients with advanced non-small cell lung cancer

被引：0
|
作者：
Tamura, N. [1 ]
Horinouchi, H. [1 ]
Sekine, K. [1 ]
Matsumoto, Y. [1 ]
Murakami, S. [1 ]
Goto, Y. [1 ]
Kanda, S. [1 ]
Fujiwara, Y. [1 ]
Yamamoto, N. [1 ]
Ohe, Y. [1 ]
机构：
[1] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
438P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of nivolumab for cytotoxic chemotherapy unfit patients with advanced non-small cell lung cancer: A phase II study
    Okuma, Y.
    Kitano, S.
    Watanabe, K.
    Yomota, M.
    Hosomi, Y.
    Zenke, Y.
    Yamamoto, N.
    ANNALS OF ONCOLOGY, 2018, 29
  • [2] Efficacy of Single-Agent Chemotherapy after Exposure to Nivolumab in Advanced Non-Small Cell Lung Cancer
    Yasuda, Y.
    Funazo, T.
    Nomizo, T.
    Tsuji, T.
    Yoshida, H.
    Sakamori, Y.
    Nagai, H.
    Ozasa, H.
    Hirai, T.
    Kim, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2076 - S2076
  • [3] Efficacy of subsequent docetaxel plus /- ramucirumab and S-1 after nivolumab for patients with advanced non-small cell lung cancer
    Tamura, Nobumasa
    Horinouchi, Hidehito
    Sekine, Katsutoshi
    Matsumoto, Yuji
    Murakami, Shuji
    Goto, Yasushi
    Kanda, Shintaro
    Fujiwara, Yutaka
    Yamamoto, Noboru
    Ohe, Yuichiro
    THORACIC CANCER, 2019, 10 (05) : 1141 - 1148
  • [4] Efficacy and Tolerability of Nivolumab in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Yamane, K.
    Takeda, K.
    Yanai, M.
    Tanaka, N.
    Izumi, H.
    Sakamoto, T.
    Yamaguchi, K.
    Yamasaki, A.
    Igishi, T.
    Eiji, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1918 - S1918
  • [5] Influence of previous chemotherapy on the efficacy of subsequent docetaxel therapy in advanced non-small cell lung cancer patients
    Goto, Yasushi
    Sekine, Ikuo
    Yamada, Kazuhiko
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Kunitoh, Hideo
    Ohe, Yuichiro
    Tamura, Tomohide
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (04) : 412 - 416
  • [6] The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer
    Tanvetyanon, Tawee
    Creelan, Benjamin C.
    Antonia, Scott J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (09) : 903 - 910
  • [7] Circadian variation in nivolumab efficacy in patients with advanced non-small cell lung cancer.
    Karabou, Abdoulaye
    Bisseux, Laurence
    Pavese, Ida
    Collon, Thierry
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Efficacy of second-line nivolumab after early time to progression on first-line cytotoxic chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)
    Ota, T.
    Kirita, K.
    Udagawa, H.
    Umemura, S.
    Matsumoto, S.
    Yoh, K.
    Niho, S.
    Goto, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] Chemotherapy in patients with advanced non-small cell lung cancer
    Price, A
    CLINICAL ONCOLOGY, 2001, 13 (06) : 480 - 482
  • [10] Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer
    Feldman, Hope
    Sepesi, Boris
    Leung, Cheuk H.
    Lin, Heather
    Weissferdt, Annikka
    Pataer, Apar
    William Jr, William N.
    Walsh, Garrett L.
    Rice, David C.
    Roth, Jack A.
    Mehran, Reza J.
    Hofstetter, Wayne L.
    Antonoff, Mara B.
    Rajaram, Ravi
    Gibbons, Don L.
    Lee, J. Jack
    Heymach, John V.
    Vaporciyan, Ara A.
    Swisher, Stephen G.
    Cascone, Tina
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 167 (04):
12345